+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Tc-99m sestamibi scintimammography for the diagnosis of breast cancer: meta-analysis and meta-regression



Tc-99m sestamibi scintimammography for the diagnosis of breast cancer: meta-analysis and meta-regression



Nuclear Medicine Communications 32(11): 980-988



Tc-99m sestamibi (MIBI) is a relatively noninvasive diagnostic modality in the evaluation of breast cancer. The purpose of this study was to review the existing literature on the accuracy of Tc-99m MIBI in the diagnosis of breast cancer. After a systematic review of English-language studies, the sensitivity, specificity, and other measures of accuracy of Tc-99m MIBI in the diagnosis of breast cancer were pooled using random-effects models. Summary receiver operating characteristic curves were used to summarize the overall test performance. Forty-five studies met our inclusion criteria. The summary estimates for Tc-99m MIBI in the diagnosis of breast cancer in the studies included were as follows: sensitivity, 0.83 [95% confidence interval (CI), 0.82-0.84]; specificity, 0.85 (95% CI, 0.83-0.86); positive likelihood ratio, 5.06 (95% CI, 4.26-6.01); negative likelihood ratio, 0.20 (95% CI, 0.17-0.24); and diagnostic odds ratio, 27.63 (95% CI, 21.63-36.10). For patients with a palpable mass, the sensitivity and specificity were 87 and 86%, respectively. For patients without a palpable mass, the sensitivity and specificity were 59 and 89%, respectively. Tc-99m MIBI has a high level of overall accuracy for the diagnosis of breast cancer.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056126564

Download citation: RISBibTeXText

PMID: 21956488

DOI: 10.1097/mnm.0b013e32834b43a9


Related references

Is Tc-99m sestamibi scintimammography useful in the prediction of neoadjuvant chemotherapy responses in breast cancer? A systematic review and meta-analysis. Nuclear Medicine Communications 37(7): 675-688, 2016

Breast cancer diagnosis by scintimammography: a meta-analysis and review of the literature. Breast Cancer Research and Treatment 80(1): 115-126, 2003

Retinol, vitamins A, C, and E and breast cancer risk: a meta-analysis and meta-regression. Cancer Causes & Control 22(10): 1383-1396, 2011

Retinol, vitamins A, C, and E and breast cancer risk: a meta-analysis and meta-regression. Cancer Causes and Control 22(10): 1383-1396, 2011

Carotenoids and breast cancer risk: a meta-analysis and meta-regression. Breast Cancer Research and Treatment 131(1): 239-253, 2012

Correlation of the BACH1 Pro919Ser polymorphism with breast cancer risk: A literature-based meta-analysis and meta-regression analysis. Experimental and Therapeutic Medicine 6(2): 435-444, 2013

Aspirin use and breast cancer risk: a meta-analysis and meta-regression of observational studies from 2001 to 2005. Pharmacoepidemiology and Drug Safety 17(2): 115-124, 2008

The plasma level of retinol, vitamins A, C and α-tocopherol could reduce breast cancer risk? A meta-analysis and meta-regression. Journal of Cancer Research and Clinical Oncology 141(4): 601-614, 2015

Surgery of primary tumors in stage IV breast cancer: an updated meta-analysis of published studies with meta-regression. Medical Oncology 29(5): 3282-3290, 2012

Accuracy of (99m)Tc-sestamibi scintimammography for breast cancer diagnosis. Experimental and Therapeutic Medicine 1(1): 205-209, 2010

A review of the cost-effectiveness of Tc-99m sestamibi scintimammography in diagnosis of breast cancer in Taiwanese women with indeterminate mammographically dense breast. Surgical Oncology 11(3): 151-155, 2002

The value of early and double phase 99Tcm-sestamibi scintimammography in the diagnosis of breast cancer. Nuclear Medicine Communications 21(4): 341-348, 2000

Comparison of 99mTc-Sestamibi scintimammography and dynamic Mr imaging as adjuncts to mammography in the diagnosis of breast cancer. Acta Radiologica 44(1): 28-34, 2003

Review of imaging techniques for the diagnosis of breast cancer: a new role of prone scintimammography using technetium-99m sestamibi. European Journal of Nuclear Medicine 21(4): 357-362, 1994

Comparison of 99mTc-sestamibi scintimammography and dynamic MR imaging as adjuncts to mammography in the diagnosis of breast cancer. Acta Radiologica 44(1): 28-34, 2003